§ Sector lens

Healthcare

Standard 9-phase methodology applied with sector-appropriate emphasis on quality gates, valuation lens, and risk framing.

Tickers covered

+12.8%

Avg. upside to FV

6.7

Avg. moat

Coverage

Ticker	Price	Fair value	Upside	Rating	Moat
ALNY Alnylam Pharmaceuticals, Inc. · Hyper-growth	$292.03 —	$665.75 Potential value $974.55	+128.0%	Strong Buy	9
DVA DaVita Inc. · Mature compounder	$183.86 —	$386.49 Potential value $490.58	+110.2%	Strong Buy	7
ARGX argenx SE · Hyper-growth	$797.77 —	$1,486.48 Potential value $2,709.48	+86.3%	Strong Buy	6.5
REGN Regeneron Pharmaceuticals Inc. · Mature compounder	$714.89 —	$1,209.72 Potential value $1,505.07	+69.2%	Strong Buy	9
CI The Cigna Group · Mature compounder	$304.37 ▲ +15.30 (+5.3%)	$478.08 Potential value $825	+57.1%	Strong Buy	7.5
BSX Boston Scientific Corporation · Mature compounder	$44.51 ▼ -9.59 (-17.7%)	$65.94 Potential value $85.81	+48.1%	Strong Buy	8
COO The Cooper Companies, Inc. · Mature compounder	$55.29 —	$78.48 Potential value $92.70	+41.9%	Strong Buy	6.5
MCK McKesson Corporation · Mature compounder	$725.17 —	$1,016.12 Potential value $1,307.92	+40.1%	Strong Buy	9
ZBH Zimmer Biomet Holdings, Inc. · Mature compounder	$89.14 —	$119.59 Potential value $185.55	+34.2%	Strong Buy	7.5
JNJ Johnson & Johnson · Mature compounder	$269.99 ▲ +47.48 (+21.3%)	$345.55 Potential value $530.18	+28.0%	Buy	9
BIIB Biogen Inc. · Mature compounder	$199.36 —	$253.08 Potential value $314.03	+26.9%	Buy	6.5
MDT Medtronic plc · Mature dividend	$76.82 —	$95.89 Potential value $113.75	+24.8%	Buy	9
PODD Insulet Corporation · Growth infrastructure	$133.93 —	$164.82 Potential value $210.43	+23.1%	Buy	7.5
ZTS Zoetis Inc. · Mature compounder	$79.62 ▲ +2.68 (+3.5%)	$95.48 Potential value $131.22	+19.9%	Buy	8.5
SOLV Solventum Corporation · Mature compounder	$86.57 —	$103.66 Potential value $129.62	+19.7%	Buy	7.2
UNH UnitedHealth Group Incorporated · Mature compounder	$376.90 · 0.00 (0.0%)	$448.25 Potential value $578.10	+18.9%	Buy	7
DGX Quest Diagnostics Incorporated · Mature dividend	$190.18 —	$226.02 Potential value $267.84	+18.9%	Buy	6.5
BAX Baxter International Inc. · Pre-profit growth	$22.80 —	$26.92 Potential value $31.12	+18.1%	Buy	5.5
SNY Sanofi · Mature dividend	$43.55 —	$51.16 Potential value $57.92	+17.5%	Buy	6.3
CVS CVS Health Corporation · Mature compounder	$93.45 ▼ -1.70 (-1.8%)	$107.29 Potential value $176.72	+14.8%	Buy	6.5
AMGN Amgen Inc. · Mature compounder	$437.23 ▲ +108.14 (+32.9%)	$492.07 Potential value $640.92	+12.5%	Buy	1
INCY Incyte Corporation · Mature compounder	$114.76 —	$126.70 Potential value $155.01	+10.4%	Hold	7.2
BDX Becton Dickinson and Company · Mature dividend	$176.80 —	$194.59 Potential value $323.86	+10.1%	Hold	7.2
HCA HCA Healthcare Inc. · Mature compounder	$459.40 ▲ +33.03 (+7.8%)	$504.46 Potential value $658.79	+9.8%	Hold	7
MRNA Moderna Inc. · Pre-profit growth	$53.27 —	$58.30 Potential value $78.75	+9.4%	Hold	3
RMD ResMed Inc. · Mature compounder	$218.89 —	$239.41 Potential value $282.29	+9.4%	Hold	9
ELV Elevance Health Inc. · Mature compounder	$434.13 ▲ +52.38 (+13.7%)	$474.64 Potential value $627.40	+9.3%	Hold	7.5
EXAS Exact Sciences Corp · Pre-profit growth	$104.91 —	$114.04 Potential value $165.46	+8.7%	Hold	6.5
CAH Cardinal Health, Inc. · Mature compounder	$228.30 —	$244.05 Potential value $320.21	+6.9%	Hold	8
GEHC GE HealthCare Technologies Inc. · Mature compounder	$64.29 —	$68.29 Potential value $81.12	+6.2%	Hold	7.5
SYK Stryker Corporation · Mature compounder	$297.60 ▲ +3.15 (+1.1%)	$313.18 Potential value $413.44	+5.2%	Hold	8.5
STE STERIS plc · Mature compounder	$214.40 —	$209.55 Potential value $249.66	-2.3%	Hold	9
COR Cencora, Inc. · Mature compounder	$340.43 ▲ +79.50 (+30.5%)	$328.59 Potential value $487.41	-3.5%	Hold	7.5
GILD Gilead Sciences Inc. · Mature dividend	$146.64 ▲ +12.58 (+9.4%)	$139.59 Potential value $273.40	-4.8%	Hold	1
TFX Teleflex Incorporated · Mature compounder	$130.43 —	$122.83 Potential value $190.97	-5.8%	Hold	6.8
MRK Merck & Co., Inc. · Mature dividend	$150.33 ▲ +38.03 (+33.9%)	$141.37 Potential value $278.92	-6.0%	Hold	1
VTRS Viatris Inc. · Mature compounder	$17.64 —	$15.91 Potential value $18.81	-9.8%	Reduce	5.5
PFE Pfizer Inc. · Mature dividend	$28.67 ▲ +2.99 (+11.6%)	$25.83 Potential value $28.85	-9.9%	Reduce	6.5
LH Labcorp Holdings Inc. · Mature compounder	$311.71 —	$263.85 Potential value $335.23	-15.3%	Reduce	7.2
IQV IQVIA Holdings Inc. · Mature compounder	$258.21 —	$215.19 Potential value $256.27	-16.7%	Reduce	7.8
DHR Danaher Corporation · Mature compounder	$223.90 ▲ +52.74 (+30.8%)	$186.58 Potential value $206.33	-16.7%	Reduce	9
ABT Abbott Laboratories · Mature dividend	$105.52 ▲ +21.20 (+25.1%)	$86.74 Potential value $139.69	-17.8%	Reduce	1
ALGN Align Technology Inc. · Mature compounder	$147.61 —	$121.31 Potential value $121.34	-17.8%	Reduce	7.5
CNC Centene Corporation · Pre-profit growth	$62.99 —	$51.46 Potential value $59.33	-18.3%	Reduce	6
WAT Waters Corporation · Mature compounder	$425.21 —	$345.34 Potential value $440.18	-18.8%	Reduce	9
MOH Molina Healthcare Inc. · Mature compounder	$209.19 —	$153.64 Potential value $188.58	-26.6%	Sell	6.5
LLY Eli Lilly and Company · Hyper-growth	$1,149.36 ▲ +174.40 (+17.9%)	$836.00 Potential value $1,051.71	-27.3%	Sell	1
EW Edwards Lifesciences Corporation · Mature compounder	$85.71 —	$62.28 Potential value $79.82	-27.3%	Sell	9
ABBV AbbVie Inc. · Mature dividend	$256.46 ▲ +53.75 (+26.5%)	$180.11 Potential value $250.84	-29.8%	Sell	1
DXCM DexCom, Inc. · Mature compounder	$85.36 —	$58.97 Potential value $74	-30.9%	Sell	9

1–50 of 62

1 / 2

October 2026 · sector commentary

Healthcare — October 2026

As of 2026-10-28 · Published 2026-10-28T07:00:08+00:00

As of 2026-10-28, the sector snapshot covered 1054 constituents. Median returns were unavailable over one month and unavailable over three months. The recorded valuation median was 25.64 across 239 observations. The market-wide sector-rotation score was unavailable. Missing values are left unavailable rather than estimated.

Info

Compare healthcare against every other sector in the sector-rotation matrix — relative-strength rank, forward P/E, and revisions delta in one frame, as of the latest published outlook.

Top by upside

ALNY

+128.0%

Alnylam Pharmaceuticals, Inc.

Strong Buy· 2026-05-13

DVA

+110.2%

DaVita Inc.

Strong Buy· 2026-09-20

ARGX

+86.3%

argenx SE